3Beard RS Jr and Bearden SE. Vascular complications of cystathionine -synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol 2011,300: H13-H26.
4Maldonado C, Soni CV, Todnem ND, Pushpakumar S, Rosenberger D, Givvimani S and Villafane J, et al. Hyperhomocysteinemia and sudden cardiac death: potential arrhythmogenic mechanisms. Curt Vasc Pharmacol 2010, 8: 64-74.
5Moshal KS, Metreveli N, Frank I and Tyagi SC. Mitochondrial MMP acti- vation, dysfunction and arrhythmogenesis in hyperhomocysteinernia. Curr Vasc Pharmacol 2008, 6: 84-92.
6Misra A, Haudek SB, Knuefermann P, Vallejo JG, Chen ZJ, Michael LH and Sivasubmmanian N, et al. Nuclear factor-KB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation 2003, 108: 3075-3078.
7Feridooni T, Hotchkiss A, Remley-Carr S, Saga Y and Pasumarthi KB. Cardiomyocyte specific ablation of p53 is not sufficient to blockdoxorubicin induced cardiac fibrosis and associated cytoskeletal changes. PLoS One 2011, 6: e22801.
8Shankar S and Srivastava RK. Involvement of Bcl-2 family members, phosphatidylinositol 3kinase/AKT and mitochondrial p53 in curcttmin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol 2007, 30: 905-918.
9Halasova E, Adamkov M, Matakova T, Vybohova D, Antosova M, Janickova M, Singliar A and Dobrota D, et al. Expression of Ki-67, Bcl-2, survivin and p53 proteins in patients with pulmonary carcinoma. Adv Exp Med Biol 2013, 756: 15-21.
10Gryko M, Pryczynicz A, Guziriska-Ustymowicz K, Kamocki Z, Zarba K, Kemona A and Kdm /3. Immunohistochemical assessment of apoptosis-associated proteins: p53, Bcl-xL, Bax and Bak in gastric cancer cells in correlation with clinical and pathomorphological factors. Adv Med Sci 2012, 71: 77-83.
